1565 related articles for article (PubMed ID: 29889418)
21. Study Insights into Gastrointestinal Cancer through the Gut Microbiota.
Kong F; Cai Y
Biomed Res Int; 2019; 2019():8721503. PubMed ID: 31341907
[TBL] [Abstract][Full Text] [Related]
22. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer?
Chattopadhyay I; Gundamaraju R; Jha NK; Gupta PK; Dey A; Mandal CC; Ford BM
Dis Markers; 2022; 2022():2941248. PubMed ID: 35178126
[TBL] [Abstract][Full Text] [Related]
23. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
[TBL] [Abstract][Full Text] [Related]
24. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites.
Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A
Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825
[TBL] [Abstract][Full Text] [Related]
25. Diet and Gut Microbiota in Health and Disease.
Shen TD
Nestle Nutr Inst Workshop Ser; 2017; 88():117-126. PubMed ID: 28346928
[TBL] [Abstract][Full Text] [Related]
26. High salt intake increases plasma trimethylamine N-oxide (TMAO) concentration and produces gut dysbiosis in rats.
Bielinska K; Radkowski M; Grochowska M; Perlejewski K; Huc T; Jaworska K; Motooka D; Nakamura S; Ufnal M
Nutrition; 2018 Oct; 54():33-39. PubMed ID: 29705499
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota imbalance and colorectal cancer.
Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
[TBL] [Abstract][Full Text] [Related]
28. Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
Bruner SD; Jobin C
Clin Pharmacol Ther; 2016 Jun; 99(6):585-7. PubMed ID: 26850686
[TBL] [Abstract][Full Text] [Related]
29. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
[TBL] [Abstract][Full Text] [Related]
30. Novel insights into microbiome in colitis and colorectal cancer.
Yang Y; Jobin C
Curr Opin Gastroenterol; 2017 Nov; 33(6):422-427. PubMed ID: 28877044
[TBL] [Abstract][Full Text] [Related]
31. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
32. The roles of microbial products in the development of colorectal cancer: a review.
Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
[TBL] [Abstract][Full Text] [Related]
33. Altered intestinal microbiota associated with colorectal cancer.
Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
[TBL] [Abstract][Full Text] [Related]
34. Dysbiotic events in gut microbiota: impact on human health.
Schippa S; Conte MP
Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
[TBL] [Abstract][Full Text] [Related]
35. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota composition modifies fecal metabolic profiles in mice.
Zhao Y; Wu J; Li JV; Zhou NY; Tang H; Wang Y
J Proteome Res; 2013 Jun; 12(6):2987-99. PubMed ID: 23631562
[TBL] [Abstract][Full Text] [Related]
37. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
38. Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.
Mohan M; Chow CT; Ryan CN; Chan LS; Dufour J; Aye PP; Blanchard J; Moehs CP; Sestak K
Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801835
[TBL] [Abstract][Full Text] [Related]
39. Diet, microbiota, and dysbiosis: a 'recipe' for colorectal cancer.
Vipperla K; O'Keefe SJ
Food Funct; 2016 Apr; 7(4):1731-40. PubMed ID: 26840037
[TBL] [Abstract][Full Text] [Related]
40. Effects of ad libitum Free-Choice Access to Freshly Squeezed Domestic White Asparagus Juice on Intestinal Microbiota Composition and Universal Bio-Markers of Immuno-Metabolic Homeostasis and General Health in Middle-Aged Female and Male C57BL/6 Mice.
Ghadimi D; Frahm SO; Röcken C; Ebsen M; Schwiertz A; Fölster-Holst R; Bockelmann W; Heller KJ
Endocr Metab Immune Disord Drug Targets; 2022; 22(4):401-414. PubMed ID: 34463231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
